Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality

Sponsor
Regina Elena Cancer Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT05918536
Collaborator
Azienda Policlinico Umberto I (Other), Istituto Ortopedico Galeazzi (Other)
45
1
42.1
1.1

Study Details

Study Description

Brief Summary

Noninterventional, prospective study of patients operated on for musculoskeletal neoplasms designed to evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT

Study Design

Study Type:
Observational
Anticipated Enrollment :
45 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality
Actual Study Start Date :
May 17, 2022
Anticipated Primary Completion Date :
May 17, 2025
Anticipated Study Completion Date :
Nov 17, 2025

Arms and Interventions

Arm Intervention/Treatment
Popolation

Diagnostic Test: evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
Noninterventional, prospective study of patients operated on for musculoskeletal neoplasms designed to evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT

Outcome Measures

Primary Outcome Measures

  1. Quality of life [Baseline]

    To evaluate the quality of the Surgical Margin in terms of the percentage of oncologically adequate resections, in patients with Musculoskeletal neoplasms undergoing navigated resection surgery with Intraoperative CT

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age: no limit

  • Patients with musculoskeletal neoplasms predominantly in complex sites

  • Patients who will have to undergo surgical resection/amputation for the management of their clinical case

  • Preparation of preoperative planning discussed at DMT

  • Surgery performed with the aid of Intraoperative CT Navigated

  • Written informed consent

Exclusion Criteria:
  • Inability to perform pre-post treatment assessment

Contacts and Locations

Locations

Site City State Country Postal Code
1 "Regina Elena" National Cancer Institute Rome Italy 00144

Sponsors and Collaborators

  • Regina Elena Cancer Institute
  • Azienda Policlinico Umberto I
  • Istituto Ortopedico Galeazzi

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Regina Elena Cancer Institute
ClinicalTrials.gov Identifier:
NCT05918536
Other Study ID Numbers:
  • RS1686/22
First Posted:
Jun 26, 2023
Last Update Posted:
Jun 26, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 26, 2023